314 related articles for article (PubMed ID: 23329375)
21. RYR1 causing distal myopathy.
Laughlin RS; Niu Z; Wieben E; Milone M
Mol Genet Genomic Med; 2017 Nov; 5(6):800-804. PubMed ID: 29178655
[TBL] [Abstract][Full Text] [Related]
22. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ
Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029
[TBL] [Abstract][Full Text] [Related]
23. Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization.
Guis S; Figarella-Branger D; Monnier N; Bendahan D; Kozak-Ribbens G; Mattei JP; Lunardi J; Cozzone PJ; Pellissier JF
Arch Neurol; 2004 Jan; 61(1):106-13. PubMed ID: 14732627
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
[TBL] [Abstract][Full Text] [Related]
25. Ryanodine myopathies without central cores--clinical, histopathologic, and genetic description of three cases.
Rocha J; Taipa R; Melo Pires M; Oliveira J; Santos R; Santos M
Pediatr Neurol; 2014 Aug; 51(2):275-8. PubMed ID: 24950660
[TBL] [Abstract][Full Text] [Related]
26. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility.
Deufel T; Golla A; Iles D; Meindl A; Meitinger T; Schindelhauer D; DeVries A; Pongratz D; MacLennan DH; Johnson KJ
Am J Hum Genet; 1992 Jun; 50(6):1151-61. PubMed ID: 1598899
[TBL] [Abstract][Full Text] [Related]
27. A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course.
Biancalana V; Rendu J; Chaussenot A; Mecili H; Bieth E; Fradin M; Mercier S; Michaud M; Nougues MC; Pasquier L; Sacconi S; Romero NB; Marcorelles P; Authier FJ; Gelot Bernabe A; Uro-Coste E; Cances C; Isidor B; Magot A; Minot-Myhie MC; Péréon Y; Perrier-Boeswillwald J; Bretaudeau G; Dondaine N; Bouzenard A; Pizzimenti M; Eymard B; Ferreiro A; Laporte J; Fauré J; Böhm J
Acta Neuropathol Commun; 2021 Sep; 9(1):155. PubMed ID: 34535181
[TBL] [Abstract][Full Text] [Related]
28. Using exome data to identify malignant hyperthermia susceptibility mutations.
Gonsalves SG; Ng D; Johnston JJ; Teer JK; Stenson PD; Cooper DN; Mullikin JC; Biesecker LG;
Anesthesiology; 2013 Nov; 119(5):1043-53. PubMed ID: 24195946
[TBL] [Abstract][Full Text] [Related]
29. Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots.
Gillies RL; Bjorksten AR; Davis M; Du Sart D
Anaesth Intensive Care; 2008 May; 36(3):391-403. PubMed ID: 18564801
[TBL] [Abstract][Full Text] [Related]
30. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV
Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078
[TBL] [Abstract][Full Text] [Related]
31. Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy.
Vattemi GNA; Rossi D; Galli L; Catallo MR; Pancheri E; Marchetto G; Cisterna B; Malatesta M; Pierantozzi E; Tonin P; Sorrentino V
Eur J Neurosci; 2022 Aug; 56(3):4214-4223. PubMed ID: 35666680
[TBL] [Abstract][Full Text] [Related]
32. Genetic variation in RYR1 and malignant hyperthermia phenotypes.
Carpenter D; Robinson RL; Quinnell RJ; Ringrose C; Hogg M; Casson F; Booms P; Iles DE; Halsall PJ; Steele DS; Shaw MA; Hopkins PM
Br J Anaesth; 2009 Oct; 103(4):538-48. PubMed ID: 19648156
[TBL] [Abstract][Full Text] [Related]
33. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility.
Monnier N; Krivosic-Horber R; Payen JF; Kozak-Ribbens G; Nivoche Y; Adnet P; Reyford H; Lunardi J
Anesthesiology; 2002 Nov; 97(5):1067-74. PubMed ID: 12411788
[TBL] [Abstract][Full Text] [Related]
34. Mouse model of severe recessive RYR1-related myopathy.
Brennan S; Garcia-Castañeda M; Michelucci A; Sabha N; Malik S; Groom L; Wei LaPierre L; Dowling JJ; Dirksen RT
Hum Mol Genet; 2019 Sep; 28(18):3024-3036. PubMed ID: 31107960
[TBL] [Abstract][Full Text] [Related]
35. Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy.
Helbling DC; Mendoza D; McCarrier J; Vanden Avond MA; Harmelink MM; Barkhaus PE; Basel D; Lawlor MW
J Neuropathol Exp Neurol; 2019 Mar; 78(3):283-287. PubMed ID: 30715496
[TBL] [Abstract][Full Text] [Related]
36. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.
Ibarra M CA; Wu S; Murayama K; Minami N; Ichihara Y; Kikuchi H; Noguchi S; Hayashi YK; Ochiai R; Nishino I
Anesthesiology; 2006 Jun; 104(6):1146-54. PubMed ID: 16732084
[TBL] [Abstract][Full Text] [Related]
37. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
Zhou H; Lillis S; Loy RE; Ghassemi F; Rose MR; Norwood F; Mills K; Al-Sarraj S; Lane RJ; Feng L; Matthews E; Sewry CA; Abbs S; Buk S; Hanna M; Treves S; Dirksen RT; Meissner G; Muntoni F; Jungbluth H
Neuromuscul Disord; 2010 Mar; 20(3):166-73. PubMed ID: 20080402
[TBL] [Abstract][Full Text] [Related]
38. [Molecular genetic analysis of the ryanodine receptor gene (RYR1) in Korean malignant hyperthermia families].
Lee H; Kim DC; Lee JH; Cho YG; Lee HS; Choi SI; Kim DS
Korean J Lab Med; 2010 Dec; 30(6):702-10. PubMed ID: 21157159
[TBL] [Abstract][Full Text] [Related]
39. Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.
Abath Neto O; Moreno CAM; Malfatti E; Donkervoort S; Böhm J; Guimarães JB; Foley AR; Mohassel P; Dastgir J; Bharucha-Goebel DX; Monges S; Lubieniecki F; Collins J; Medne L; Santi M; Yum S; Banwell B; Salort-Campana E; Rendu J; Fauré J; Yis U; Eymard B; Cheraud C; Schneider R; Thompson J; Lornage X; Mesrob L; Lechner D; Boland A; Deleuze JF; Reed UC; Oliveira ASB; Biancalana V; Romero NB; Bönnemann CG; Laporte J; Zanoteli E
Neuromuscul Disord; 2017 Nov; 27(11):975-985. PubMed ID: 28818389
[TBL] [Abstract][Full Text] [Related]
40. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.
Barone V; Massa O; Intravaia E; Bracco A; Di Martino A; Tegazzin V; Cozzolino S; Sorrentino V
J Med Genet; 1999 Feb; 36(2):115-8. PubMed ID: 10051009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
